Your institution may have access to this item. Find your institution then sign in to continue.
Title
A meta-analysis of efficacy and safety of the new α1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH.
Authors
Wu, Y J; Dong, Q; Liu, L R; Wei, Q
Abstract
Recently several clinical trials have focused on the efficacy and safety of silodosin, a new, highly selective α1A-blocker. We tried to verify silodosin's superiority to placebo and non-inferiority to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with BPH.
Publication
Prostate cancer and prostatic diseases, 2013, Vol 16, Issue 1, p79